Krystal Biotech, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for Krystal Biotech, Inc. (KRYS) is 46.53

According to Krystal Biotech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 46.53. This represents a change of 68.31% compared to the average of 27.64 of the last 4 quarters.

Krystal Biotech, Inc. (KRYS) Historical PE Ratio (quarterly & annually)

How has KRYS PE Ratio performed in the past?

The mean historical PE Ratio of Krystal Biotech, Inc. over the last ten years is 20.92. The current 46.53 PE Ratio has changed 22.14% with respect to the historical average. Over the past ten years (40 quarters), KRYS's PE Ratio was at its highest in in the March 2024 quarter at 1.47K. The PE Ratio was at its lowest in in the December 2019 quarter at -44.66.

Krystal Biotech, Inc. (KRYS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Krystal Biotech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Krystal Biotech, Inc. (KRYS) Average PE Ratio

How has KRYS PE Ratio performed in the past?

The current PE Ratio of Krystal Biotech, Inc. (KRYS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Krystal Biotech, Inc. (KRYS) PE Ratio vs. Peers

How is KRYS’s PE Ratio compared to its peers?

Krystal Biotech, Inc.’s PE Ratio is greater than CRISPR Therapeutics AG (-8.70), greater than Vaxcyte, Inc. (-7.47), greater than PTC Therapeutics, Inc. (-33.84), greater than Arrowhead Pharmaceuticals, Inc. (-38.23), greater than TG Therapeutics, Inc. (16.74), less than Alkermes plc (48.38), greater than Metsera, Inc. (-23.34), greater than Arcellx, Inc. (-28.27), greater than Protagonist Therapeutics, Inc. (-62.63), greater than Teleflex Incorporated (-5.57),

Build a custom stock screener for Krystal Biotech, Inc. (KRYS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Krystal Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Krystal Biotech, Inc. (KRYS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Krystal Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.